Zahra Aminzade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zahra Aminzade has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Masoud Etemadifar
Department of Functional Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4 shared publications- Mehri Salari
School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran
4 shared publications - Sepand Tehrani Fateh
Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publications Mehri Salari
Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 shared publications- Farzad Ashrafi
Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications Mohammad Gholamnezhad
Affiliation Clinical Research Development Unit, Yasuj University of Medical Sciences, Yasuj, Iran
2 shared publications
Latest Publications
- Open Access
- 26 May 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (6) , 2116-2121
Ovarian preservation in a pregnant woman with a leaking dermoid cyst and ovarian torsion: a case study and review of diagnostic and therapeutic challenges
Background: Ovarian cysts are common during pregnancy, and dermoid cysts are common benign ovarian tumors, affecting approximately 0.3% of pregnancies, most often detected in the second trimester. Hormonal changes and pressure from the growing uterus can cause these cysts to become symptomatic, leading to complications such as torsion. Torsion presents diagnostic and management challenges, requiring prompt intervention to prevent negative outcomes for both the mother and fetus. In managing ovarian cyst torsion during pregnancy, preserving ovarian tissue is crucial to maintain fertility and endocrine function, especially in women of reproductive age. Case presentation: A 27-year-old primigravida at 18 weeks of gestation presented with acute abdominal pain due to a leaking dermoid cyst with ovarian torsion. Pre-pregnancy imaging had identified a 6-cm dermoid cyst in the right ovary, which was completely twisted with a small cyst rupture and leakage of contents, but with viable ovarian tissue. The appendix was adherent to the cyst at the site of torsion. Detorsion of the ovary, cystectomy with ovarian preservation, and appendectomy were performed. Postoperative care included vaginal progesterone to prevent miscarriage, and she delivered at 39 weeks without complications. Clinical discussion: Ovarian torsion in pregnancy is a rare but serious condition, occurring in fewer than 4 in 10 000 pregnancies and requiring prompt diagnosis and intervention. The decision between conservative management and surgery depends on factors such as cyst size, gestational age, and associated complications. Laparoscopy is preferred in early pregnancy for its minimally invasive benefits, but laparotomy is often necessary for larger cysts or advanced gestation. This case emphasizes the importance of timely surgical intervention to preserve ovarian function and prevent adverse maternal and fetal outcomes. Conclusion: Managing dermoid cysts in pregnancy requires a delicate balance between timely surgical intervention and minimizing risks to the fetus. This case highlights the importance of individualized management, multidisciplinary collaboration, and early recognition of complications such as ovarian torsion. A structured approach to diagnosis and treatment can lead to successful ovarian preservation and optimal reproductive outcomes.
- 26 May 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (6) , 2116-2121
Open AccessOvarian preservation in a pregnant woman with a leaking dermoid cyst and ovarian torsion: a case study and review of diagnostic and therapeutic challenges
Background: Ovarian cysts are common during pregnancy, and dermoid cysts are common benign ovarian tumors, affecting approximately 0.3% of pregnancies, most often detected in the second trimester. Hormonal changes and pressure from the growing uterus can cause these cysts to become symptomatic, leading to complications such as torsion. Torsion presents diagnostic and management challenges, requiring prompt intervention to prevent negative outcomes for both the mother and fetus. In managing ovarian cyst torsion during pregnancy, preserving ovarian tissue is crucial to maintain fertility and endocrine function, especially in women of reproductive age. Case presentation: A 27-year-old primigravida at 18 weeks of gestation presented with acute abdominal pain due to a leaking dermoid cyst with ovarian torsion. Pre-pregnancy imaging had identified a 6-cm dermoid cyst in the right ovary, which was completely twisted with a small cyst rupture and leakage of contents, but with viable ovarian tissue. The appendix was adherent to the cyst at the site of torsion. Detorsion of the ovary, cystectomy with ovarian preservation, and appendectomy were performed. Postoperative care included vaginal progesterone to prevent miscarriage, and she delivered at 39 weeks without complications. Clinical discussion: Ovarian torsion in pregnancy is a rare but serious condition, occurring in fewer than 4 in 10 000 pregnancies and requiring prompt diagnosis and intervention. The decision between conservative management and surgery depends on factors such as cyst size, gestational age, and associated complications. Laparoscopy is preferred in early pregnancy for its minimally invasive benefits, but laparotomy is often necessary for larger cysts or advanced gestation. This case emphasizes the importance of timely surgical intervention to preserve ovarian function and prevent adverse maternal and fetal outcomes. Conclusion: Managing dermoid cysts in pregnancy requires a delicate balance between timely surgical intervention and minimizing risks to the fetus. This case highlights the importance of individualized management, multidisciplinary collaboration, and early recognition of complications such as ovarian torsion. A structured approach to diagnosis and treatment can lead to successful ovarian preservation and optimal reproductive outcomes.
- Top Cited PapersOpen Access
- 8 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0345076
Prevalence, predictors, and clinical relevance of drug–drug interactions in outpatient prescribing: A national cross-sectional study
Background: Drug–drug interactions (DDIs) represent a major preventable cause of medication-related harm globally. Their prevalence varies across health systems, but common drivers include polypharmacy, aging populations, and specialty-specific prescribing patterns. Large-scale pharmacoepidemiologic analyses of real-world prescription data can clarify the magnitude of the problem and inform strategies to reduce risks. Methods: This retrospective study included 2,365,811 outpatient prescriptions (982,102 patients) from Tehran, Iran. The top 100 most prescribed medications were screened for potential DDIs via Micromedex®. Interactions were classified as contraindicated, major, or moderate. Logistic regression identified demographic, specialty, and prescription-level predictors. Results: Potential DDIs occurred in 46.1% of prescriptions, with 57.8% of patients affected. Major DDIs (62.6%) dominated, followed by moderate (32.8%) and contraindicated (4.6%). ASA was a frequent contributor to high-risk pairs. Contraindicated interactions were largely NSAID duplications, most common in orthopedics and emergency medicine. Psychiatry and cardiology prescriptions showed the highest prevalence, while polypharmacy strongly predicted DDIs, with incremental risks amplified in older adults. Conclusions: Outpatient DDIs represent a substantial burden in routine care, comparable to international reports. Prevention requires comprehensive strategies, including e-prescribing with CDSS, pharmacist-led reviews, patient education on OTC use, and policy interventions to limit reimbursement of unsafe combinations.
- 8 April 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (4) , e0345076
Top Cited PapersOpen AccessPrevalence, predictors, and clinical relevance of drug–drug interactions in outpatient prescribing: A national cross-sectional study
Background: Drug–drug interactions (DDIs) represent a major preventable cause of medication-related harm globally. Their prevalence varies across health systems, but common drivers include polypharmacy, aging populations, and specialty-specific prescribing patterns. Large-scale pharmacoepidemiologic analyses of real-world prescription data can clarify the magnitude of the problem and inform strategies to reduce risks. Methods: This retrospective study included 2,365,811 outpatient prescriptions (982,102 patients) from Tehran, Iran. The top 100 most prescribed medications were screened for potential DDIs via Micromedex®. Interactions were classified as contraindicated, major, or moderate. Logistic regression identified demographic, specialty, and prescription-level predictors. Results: Potential DDIs occurred in 46.1% of prescriptions, with 57.8% of patients affected. Major DDIs (62.6%) dominated, followed by moderate (32.8%) and contraindicated (4.6%). ASA was a frequent contributor to high-risk pairs. Contraindicated interactions were largely NSAID duplications, most common in orthopedics and emergency medicine. Psychiatry and cardiology prescriptions showed the highest prevalence, while polypharmacy strongly predicted DDIs, with incremental risks amplified in older adults. Conclusions: Outpatient DDIs represent a substantial burden in routine care, comparable to international reports. Prevention requires comprehensive strategies, including e-prescribing with CDSS, pharmacist-led reviews, patient education on OTC use, and policy interventions to limit reimbursement of unsafe combinations.
- Top Cited Papers
- 7 April 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (5) , 1285-1293
Association Between Real‐Time Alerts in Electronic Prescribing Systems and Potentially Inappropriate Prescribing Among Older Adults
Background: Older adults are highly susceptible to adverse effects from potentially inappropriate medications (PIMs). Real‐time clinical decision support systems (CDSS) may reduce unsafe prescribing; yet evidence from low‐ and middle‐income countries is limited. This study assessed the association between a national electronic alert system and outpatient PIM prescribing in Iran. Methods: We examined 230,719 electronic outpatient prescriptions for adults aged 65 years and older. Prescriptions from May to August 2023 (pre‐alert) were compared with those from May to August 2024 (post‐alert). The primary outcome was the proportion of prescriptions containing ≥ 1 PIM, defined using the 2023 AGS Beers Criteria. Subgroup analyses stratified outcomes by age, sex, physician specialty, and drug class. Results: Across 2023–2024, 230,719 prescriptions were recorded. After alert implementation, the greatest reductions occurred in adults aged 85–100 years (−9.85%) and in women (−7.89%). Significant declines were also observed in gastrointestinal drugs (−14.14%), pain medications (−11.99%), central nervous system agents (−3.03%), antihistamines (−4.60%), and in specific medications including ketorolac, clidinium‐chlordiazepoxide, methocarbamol, nortriptyline, chlorpheniramine, indomethacin, and dicyclomine. By specialty, the largest reductions were seen in Surgery (−18.13%), Internal Medicine (−12.56%), and General Practice (−6.99%). Conclusions: A national, real‐time, non‐interruptive alert system was associated with meaningful reductions in PIM prescribing among older adults. Scalable CDSS tools may enhance medication safety in resource‐constrained settings.
- 7 April 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (5) , 1285-1293
Top Cited PapersAssociation Between Real‐Time Alerts in Electronic Prescribing Systems and Potentially Inappropriate Prescribing Among Older Adults
Background: Older adults are highly susceptible to adverse effects from potentially inappropriate medications (PIMs). Real‐time clinical decision support systems (CDSS) may reduce unsafe prescribing; yet evidence from low‐ and middle‐income countries is limited. This study assessed the association between a national electronic alert system and outpatient PIM prescribing in Iran. Methods: We examined 230,719 electronic outpatient prescriptions for adults aged 65 years and older. Prescriptions from May to August 2023 (pre‐alert) were compared with those from May to August 2024 (post‐alert). The primary outcome was the proportion of prescriptions containing ≥ 1 PIM, defined using the 2023 AGS Beers Criteria. Subgroup analyses stratified outcomes by age, sex, physician specialty, and drug class. Results: Across 2023–2024, 230,719 prescriptions were recorded. After alert implementation, the greatest reductions occurred in adults aged 85–100 years (−9.85%) and in women (−7.89%). Significant declines were also observed in gastrointestinal drugs (−14.14%), pain medications (−11.99%), central nervous system agents (−3.03%), antihistamines (−4.60%), and in specific medications including ketorolac, clidinium‐chlordiazepoxide, methocarbamol, nortriptyline, chlorpheniramine, indomethacin, and dicyclomine. By specialty, the largest reductions were seen in Surgery (−18.13%), Internal Medicine (−12.56%), and General Practice (−6.99%). Conclusions: A national, real‐time, non‐interruptive alert system was associated with meaningful reductions in PIM prescribing among older adults. Scalable CDSS tools may enhance medication safety in resource‐constrained settings.
- Open Access
- 17 January 2023
- Published by Knowledge E DMCC in Current Journal of Neurology
- Vol. 21 (4) , 256-258
Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality
The Article Abstract is not available.
- 17 January 2023
- Published by Knowledge E DMCC in Current Journal of Neurology
- Vol. 21 (4) , 256-258
Open AccessLimited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality
The Article Abstract is not available.
- Open Access
- 12 January 2023
- Published by Wiley in Mediators of Inflammation
- Vol. 2023, 1-11
Attenuation of Inflammatory Responses in Breast and Ovarian Cancer Cells by a Novel Chalcone Derivative and Its Increased Potency by Curcumin
Background. Breast and ovarian cancers are two common malignancies in women and a leading cause of death globally. The aim of the present study was to explore the effects of a novel chalcone derivative 1-(4-(methylsulfonyl)phenyl)-3-(phenylthio)-3-(p-tolyl)propane-1-one (MPP) individually or combined with curcumin, a well-known herbal medicine with anticancer properties, as a new combination therapy on inflammatory pathways in breast and ovarian cancer cell lines. Methods. LPS-induced NF-κB DNA-binding activity and the levels of proinflammatory cytokines were measured in the MPP- and MPP-curcumin combination-treated MDA-MB-231 and SKOV3 cells by ELISA-based methods. The expression of COX2, INOS, and MMP9 genes and nitrite levels was also evaluated by real-time qRT-PCR and Griess method, respectively. IκB levels were evaluated by Western blotting. Results. MPP significantly inhibited the DNA-binding activity of NF-κB in each cell line and subsequently suppressed the expression of downstream genes including COX2, MMP9, and INOS. The levels of proinflammatory cytokines, as well as NO, were also decreased in response to MPP. All the effects of MPP were enhanced by the addition of curcumin. MPP, especially when combined with curcumin, caused a remarkable increase in the concentration of IκB. Conclusion. MPP and its coadministration with curcumin effectively reduced the activity of the NF-κB signaling pathway, leading to a reduced inflammatory response in the environment of cancer cells. Thus, MPP, either alone or combined with curcumin, might be considered an effective remedy for the suppression of inflammatory processes in breast and ovarian cancer cells.
- 12 January 2023
- Published by Wiley in Mediators of Inflammation
- Vol. 2023, 1-11
Open AccessAttenuation of Inflammatory Responses in Breast and Ovarian Cancer Cells by a Novel Chalcone Derivative and Its Increased Potency by Curcumin
Background. Breast and ovarian cancers are two common malignancies in women and a leading cause of death globally. The aim of the present study was to explore the effects of a novel chalcone derivative 1-(4-(methylsulfonyl)phenyl)-3-(phenylthio)-3-(p-tolyl)propane-1-one (MPP) individually or combined with curcumin, a well-known herbal medicine with anticancer properties, as a new combination therapy on inflammatory pathways in breast and ovarian cancer cell lines. Methods. LPS-induced NF-κB DNA-binding activity and the levels of proinflammatory cytokines were measured in the MPP- and MPP-curcumin combination-treated MDA-MB-231 and SKOV3 cells by ELISA-based methods. The expression of COX2, INOS, and MMP9 genes and nitrite levels was also evaluated by real-time qRT-PCR and Griess method, respectively. IκB levels were evaluated by Western blotting. Results. MPP significantly inhibited the DNA-binding activity of NF-κB in each cell line and subsequently suppressed the expression of downstream genes including COX2, MMP9, and INOS. The levels of proinflammatory cytokines, as well as NO, were also decreased in response to MPP. All the effects of MPP were enhanced by the addition of curcumin. MPP, especially when combined with curcumin, caused a remarkable increase in the concentration of IκB. Conclusion. MPP and its coadministration with curcumin effectively reduced the activity of the NF-κB signaling pathway, leading to a reduced inflammatory response in the environment of cancer cells. Thus, MPP, either alone or combined with curcumin, might be considered an effective remedy for the suppression of inflammatory processes in breast and ovarian cancer cells.
- 12 February 2022
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 60, 103664
Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS
- 12 February 2022
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 60, 103664
Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS
- Open Access
- 9 December 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (12) , e05204
Deep brain stimulation of anteromedial globus pallidus internus improved OCD rather than tics in a Gilles de la Tourette syndrome patient
A 32‐year‐old gentleman with refractory Gilles de la Tourette syndrome went on a DBS procedure on anteromedial globus pallidus internus. At the most suitable adjustment, the OCD component of his disease improved almost completely while his tics remained unchanged which was in contrast with other previous studies. Moreover, variations in symptoms were seen in response to different adjustments. We discuss that these variations and fluctuations in the therapeutic outcomes may be due to differences in physiological conditions of tic‐ or OCD‐specified pathways and areas including distinct stimulation threshold and occurrence of neuroplasticity in neural circuits which may determine the responsiveness of each pathway or circuit to a specific stimulus. At last, we suggest that pathways and circuits should be targeted for DBS rather than single components; as these components may be involved in multiple pathways, related to different pathophysiological states.
- 9 December 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (12) , e05204
Open AccessDeep brain stimulation of anteromedial globus pallidus internus improved OCD rather than tics in a Gilles de la Tourette syndrome patient
A 32‐year‐old gentleman with refractory Gilles de la Tourette syndrome went on a DBS procedure on anteromedial globus pallidus internus. At the most suitable adjustment, the OCD component of his disease improved almost completely while his tics remained unchanged which was in contrast with other previous studies. Moreover, variations in symptoms were seen in response to different adjustments. We discuss that these variations and fluctuations in the therapeutic outcomes may be due to differences in physiological conditions of tic‐ or OCD‐specified pathways and areas including distinct stimulation threshold and occurrence of neuroplasticity in neural circuits which may determine the responsiveness of each pathway or circuit to a specific stimulus. At last, we suggest that pathways and circuits should be targeted for DBS rather than single components; as these components may be involved in multiple pathways, related to different pathophysiological states.
- Open Access
- 24 August 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04695
Case series: New‐onset freezing of gait in combined use of deep brain stimulation and Levodopa
Concurrent use of DBS and levodopa in Parkinson's disease patients can lead to freezing of gait. This phenomenon may be due to an inverted‐U‐Shaped function of dopamine.
- 24 August 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (8) , e04695
Open AccessCase series: New‐onset freezing of gait in combined use of deep brain stimulation and Levodopa
Concurrent use of DBS and levodopa in Parkinson's disease patients can lead to freezing of gait. This phenomenon may be due to an inverted‐U‐Shaped function of dopamine.
- 1 August 2021
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 89, 90-92
Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
- 1 August 2021
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 89, 90-92
Parkinson's disease patients may have higher rates of Covid-19 mortality in Iran
- Open Access
- 24 July 2021
- Published by Wiley
Deep brain stimulation of Anteromedial Globus Pallidus internus improved OCD rather than tics in a Tourette's syndrome patient
After performing DBS surgery on a patient with Tourette syndrome, significant improvement was observed in OCD, but the tic remained unchanged, which contradicts previous studies. Herein we discuss that fluctuations in the therapeutic outcomes may be due to differences in physiological conditions tic- or OCD-specified pathways.
- 24 July 2021
- Published by Wiley
Open AccessDeep brain stimulation of Anteromedial Globus Pallidus internus improved OCD rather than tics in a Tourette's syndrome patient
After performing DBS surgery on a patient with Tourette syndrome, significant improvement was observed in OCD, but the tic remained unchanged, which contradicts previous studies. Herein we discuss that fluctuations in the therapeutic outcomes may be due to differences in physiological conditions tic- or OCD-specified pathways.